4.8 Article

Chronic Stable Angina

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 374, Issue 12, Pages 1167-1176

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMcp1502240

Keywords

-

Funding

  1. Abiomed
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. Daiichi Sankyo
  5. Eli Lilly
  6. Janssen
  7. Stealth Peptides
  8. Medicines Company
  9. Angel Medical Systems
  10. Biotie Therapies
  11. Faculty Connection
  12. Merck
  13. Medscape
  14. Gilead Sciences

Ask authors/readers for more resources

A 73-year-old farmer with a 15-month history of stable angina presents for consultation. He has curtailed his farming activity to avoid chest discomfort, for which he uses nitroglycerin (0.4 mg sublingually) approximately 3 times per month. His heart rate is 59 beats per minute, and his blood pressure is 132/72 mm Hg. He had unstable angina 12 years earlier, and a drug-eluting stent was implanted in his left anterior descending artery; no other obstructive coronary artery disease was noted at that time. His medications include aspirin, lisinopril (20 mg daily) for hypertension, and atorvastatin (40 mg daily). How should this case be evaluated and managed?

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available